Phase II Study of Combination of Nab-Paclitaxel and Gemcitabine for Relapsed Small Cell Lung Cancer (SCLC)

被引：1
|
作者：
Furqan, M. [1 ]
Zhang, J. [1 ]
Clamon, G. [1 ]
Abu-Hejleh, T. [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Med, Iowa City, IA 52242 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Gemcitabine; nab-paclitaxel; small cell lung cancer;
D O I：
10.1016/j.jtho.2018.08.1378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.12-02
引用
收藏
页码：S791 / S791
页数：1
相关论文
共 50 条
  • [1] Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer
    Byrne, Margaret M.
    Sutamtewagul, Grerk
    Zeitler, William
    Mott, Sarah L.
    Zamba, Gideon K. D.
    Kojadinovic, Arsenije
    Zhang, Jun
    Abu-Hejleh, Taher
    Clamon, Gerald
    Furqan, Muhammad
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [2] Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
    Francesco Gelsomino
    Marcello Tiseo
    Fausto Barbieri
    Ferdinando Riccardi
    Luigi Cavanna
    Antonio Frassoldati
    Angelo Delmonte
    Lucia Longo
    Claudio Dazzi
    Saverio Cinieri
    Ida Colantonio
    Francesca Sperandi
    Giuseppe Lamberti
    Stefano Brocchi
    Lorenzo Tofani
    Luca Boni
    Andrea Ardizzoni
    British Journal of Cancer, 2020, 123 : 26 - 32
  • [3] Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
    Gelsomino, Francesco
    Tiseo, Marcello
    Barbieri, Fausto
    Riccardi, Ferdinando
    Cavanna, Luigi
    Frassoldati, Antonio
    Delmonte, Angelo
    Longo, Lucia
    Dazzi, Claudio
    Cinieri, Saverio
    Colantonio, Ida
    Sperandi, Francesca
    Lamberti, Giuseppe
    Brocchi, Stefano
    Tofani, Lorenzo
    Boni, Luca
    Ardizzoni, Andrea
    BRITISH JOURNAL OF CANCER, 2020, 123 (01) : 26 - 32
  • [4] Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
    Francesco Gelsomino
    Marcello Tiseo
    Fausto Barbieri
    Ferdinando Riccardi
    Luigi Cavanna
    Antonio Frassoldati
    Angelo Delmonte
    Lucia Longo
    Claudio Dazzi
    Saverio Cinieri
    Ida Colantonio
    Francesca Sperandi
    Giuseppe Lamberti
    Stefano Brocchi
    Lorenzo Tofani
    Luca Boni
    Andrea Ardizzoni
    British Journal of Cancer, 2021, 125 : 306 - 306
  • [5] Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL)
    Gelsomino, F.
    Tiseo, M.
    Barbieri, F.
    Riccardi, F.
    Cavanna, L.
    Frassoldati, A.
    Delmonte, A.
    Longo, L.
    Dazzi, C.
    Cinieri, S.
    Colantonio, I.
    Tognetto, M.
    Baldari, D.
    Tofani, L.
    Ardizzoni, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Carboplatin plus nab-paclitaxel for recurrent small cell lung cancer: A phase II study
    Ikeda, Naoya
    Arai, Ryo
    Soda, Sayo
    Inoue, Takashi
    Uchida, Nobuhiko
    Nakamura, Yusuke
    Masawa, Meitetsu
    Kushima, Yoshitomo
    Okutomi, Hiroaki
    Takemasa, Akihiro
    Shimizu, Yasuo
    Niho, Seiji
    THORACIC CANCER, 2022, 13 (09) : 1342 - 1348
  • [7] Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer
    Matsui, Yohei
    Yamada, Tadaaki
    Morimoto, Kenji
    Katayama, Yuki
    Hiranuma, Osamu
    Shiotsu, Shinsuke
    Tamiya, Nobuyo
    Takeda, Takayuki
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    ANTICANCER RESEARCH, 2022, 42 (10) : 4921 - 4928
  • [8] A Phase II study of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer.
    Zhao, Yannan
    Lv, Fangfang
    Chen, Shen
    Lu, Yunhua
    Cao, Enying
    Wang, Zhonghua
    Zhang, Jian
    Zhang, Sheng
    Cao, Jun
    Zheng, Chunlei
    Wang, Leiping
    Wang, Biyun
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer
    Wan, Rui
    Guo, Yanrong
    Hao, Xuezhi
    Wang, Zhijie
    Duan, Jianchun
    Wang, Jie
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [10] Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (vol 123, pg 26, 2020)
    Gelsomino, Francesco
    Tiseo, Marcello
    Barbieri, Fausto
    Riccardi, Ferdinando
    Cavanna, Luigi
    Frassoldati, Antonio
    Delmonte, Angelo
    Longo, Lucia
    Dazzi, Claudio
    Cinieri, Saverio
    Colantonio, Ida
    Sperandi, Francesca
    Lamberti, Giuseppe
    Brocchi, Stefano
    Tofani, Lorenzo
    Boni, Luca
    Ardizzoni, Andrea
    BRITISH JOURNAL OF CANCER, 2021, 125 (02) : 306 - 306
12345